SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-026257
Filing Date
2023-09-19
Accepted
2023-09-19 08:22:21
Documents
13
Period of Report
2023-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20230914_8k.htm   iXBRL 8-K 34761
  Complete submission text file 0001437749-23-026257.txt   193677

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clnn-20230918.xsd EX-101.SCH 3944
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20230918_def.xml EX-101.DEF 14285
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20230918_lab.xml EX-101.LAB 18913
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20230918_pre.xml EX-101.PRE 14372
7 EXTRACTED XBRL INSTANCE DOCUMENT clnn20230914_8k_htm.xml XML 4748
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 231262542
SIC: 2834 Pharmaceutical Preparations